530 results on '"Wahlund, L.-O."'
Search Results
2. EFNS task force: the use of neuroimaging in the diagnosis of dementia
3. Conversion from preclinical to clinical stage of Alzheimer’s disease as shown by decline of cognitive function in carriers of the Swedish APP-mutation
4. Mild cognitive impairment — an early stage of Alzheimer’s disease?
5. Alzheimer’s Disease With and Without Familial Aggregation: A Case for Phenotypical Similarity
6. Corpus callosum atrophy as a predictor of age-related cognitive and motor impairment: A 3-year follow-up of the LADIS study cohort
7. Practical cut-offs for visual rating scales of medial temporal, frontal and posterior atrophy in Alzheimerʼs disease and mild cognitive impairment
8. White matter changes in familial Alzheimerʼs disease
9. The influence of negative life events on hippocampal and amygdala volumes in old age: a life-course perspective
10. Genome-wide association with MRI atrophy measures as a quantitative trait locus for Alzheimer's disease
11. Do cardiovascular risk factors explain the link between white matter hyperintensities and brain volumes in old age? A population-based study
12. Transfer of omega-3 fatty acids across the blood–brain barrier after dietary supplementation with a docosahexaenoic acid-rich omega-3 fatty acid preparation in patients with Alzheimerʼs disease: the OmegAD study
13. The association between biomarkers in cerebrospinal fluid and structural changes in the brain in patients with Alzheimerʼs disease
14. Influence of age, disease onset and ApoE4 on visual medial temporal lobe atrophy cut-offs
15. Harmonized diagnostic criteria for Alzheimerʼs disease: recommendations
16. White matter hyperintensities and medial temporal lobe atrophy in clinical subtypes of mild cognitive impairment: the DESCRIPA study
17. Deep frontal and periventricular age related white matter changes but not basal ganglia and infratentorial hyperintensities are associated with falls: cross sectional results from the LADIS study
18. Self-perceived memory impairment and cognitive performance in an elderly independent population with age-related white matter changes
19. Clinical significance of corpus callosum atrophy in a mixed elderly population
20. Decreased lysophosphatidylcholine/phosphatidylcholine ratio in cerebrospinal fluid in Alzheimer’s disease
21. Classification and prediction of clinical diagnosis of Alzheimerʼs disease based on MRI and plasma measures of α-/γ-tocotrienols and γ-tocopherol
22. An MRI-based index to measure the severity of Alzheimerʼs disease-like structural pattern in subjects with mild cognitive impairment
23. CSF markers related to pathogenetic mechanisms in Alzheimer's disease
24. Alzheimer's disease is not associated with altered concentrations of the nitric oxide synthase inhibitor asymmetric dimethylarginine in cerebrospinal fluid
25. Neuroimaging tools to rate regional atrophy, subcortical cerebrovascular disease, and regional cerebral blood flow and metabolism: consensus paper of the EADC
26. Longitudinal CSF and MRI biomarkers improve the diagnosis of mild cognitive impairment
27. Treatment of dementia - con: MT 2-6
28. Medial temporal lobe is vulnerable to vascular risk factors in men: a population-based study
29. Complement activation in Alzheimerʼs disease: P90
30. Relationship between baseline white-matter changes and development of late-life depressive symptoms: 3-year results from the LADIS study
31. Low Levels of High Density Lipoprotein Increase the Severity of Cerebral White Matter Changes:Implications for Prevention and Treatment of Cerebrovascular Diseases
32. Neurological signs associated with cerebral age-related white matter changes: the LADIS (Leukoaraiosis And DISability) study: SC208
33. Severity of age-related white matter changes predicts stroke occurrence in elderly subjects with non-disabling neurological complaints: SC101
34. Graded response in brain areas that represent observed action
35. EEG-microstates in mild memory impairment and Alzheimer's disease: possible association with disturbed information processing
36. ON THE ETIOLOGY OF INCIDENT BRAIN LACUNES: LONGITUDINAL OBSERVATIONS FROM THE LADIS STUDY: 2
37. Reliability and Sensitivity of Visual Scales versus Volumetry for Evaluating White Matter Hyperintensity Progression
38. White matter changes and late-life depressive symptoms: Longitudinal study
39. Diabetes mellitus, hypertension and medial temporal lobe atrophy: the LADIS study
40. Conversion from preclinical to clinical stage of Alzheimer’s disease as shown by decline of cognitive function in carriers of the Swedish APP-mutation
41. Neurochemical aftermath of amateur boxing
42. Medial temporal lobe atrophy and white matter hyperintensities are associated with mild cognitive deficits in non-disabled elderly people: the LADIS study
43. Mild cognitive impairment: a cross-national comparison
44. Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
45. Age-related white matter changes as predictor of disability in the elderly: The Leukoaraiosis and Disability (Ladis) Project
46. CT and MRI Rating of White Matter Lesions
47. Mild cognitive impairment — an early stage of Alzheimer’s disease?
48. Dementia: diagnostics, early treatment, and assistance from family members
49. Magnetic resonance imaging and computed tomography in Alzheimer's disease
50. Biological markers and diagnostic investigations in Alzheimer's disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.